168 related articles for article (PubMed ID: 35738484)
1. Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms.
Yekani M; Rezaee MA; Beheshtirouy S; Baghi HB; Bazmani A; Farzinazar A; Memar MY; Sóki J
Anaerobe; 2022 Aug; 76():102606. PubMed ID: 35738484
[TBL] [Abstract][Full Text] [Related]
2. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
3. Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction.
Wallace MJ; Jean S; Wallace MA; Burnham CD; Dantas G
mBio; 2022 Feb; 13(1):e0360321. PubMed ID: 35038926
[TBL] [Abstract][Full Text] [Related]
4. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
5. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
Fernández-Canigia L; Litterio M; Legaria MC; Castello L; Predari SC; Di Martino A; Rossetti A; Rollet R; Carloni G; Bianchini H; Cejas D; Radice M; Gutkind G;
Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
[TBL] [Abstract][Full Text] [Related]
6. Frequency and associated factors for carbapenem-non-susceptible Bacteroides fragilis group bacteria colonization in hospitalized patients: Case control study in a university hospital in Turkey.
Ulger Toprak N; Akgul O; Bilgin H; Ozaydin AN; Altinkanat Gelmez G; Sayin E; Sili U; Korten V; Soyletir G
Indian J Med Microbiol; 2021; 39(4):518-522. PubMed ID: 33812722
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive investigation of antibiotic resistance gene content in cfiA-harboring Bacteroides fragilis isolates of human and animal origins by whole genome sequencing.
Cao H; Liu MC; Tong MK; Jiang S; Chow KH; To KK; Tse CW; Ho PL
Int J Med Microbiol; 2022 Aug; 312(6):151559. PubMed ID: 35961233
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical strains.
Kierzkowska M; Majewska A; Karłowicz K; Pituch H
Med Microbiol Immunol; 2023 Jun; 212(3):231-240. PubMed ID: 37178261
[TBL] [Abstract][Full Text] [Related]
9. Fatal sepsis caused by multidrug-resistant Bacteroides fragilis, harboring a cfiA gene and an upstream insertion sequence element, in Japan.
Nakamura I; Aoki K; Miura Y; Yamaguchi T; Matsumoto T
Anaerobe; 2017 Apr; 44():36-39. PubMed ID: 28108390
[TBL] [Abstract][Full Text] [Related]
10. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.
Pumbwe L; Wareham DW; Aduse-Opoku J; Brazier JS; Wexler HM
Clin Microbiol Infect; 2007 Feb; 13(2):183-189. PubMed ID: 17328731
[TBL] [Abstract][Full Text] [Related]
12. New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Jeong SH; Lee K; Kim JM; Chong Y
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):343-8. PubMed ID: 20226324
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
14. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.
Fang H; Edlund C; Hedberg M; Nord CE
Int J Antimicrob Agents; 2002 May; 19(5):361-70. PubMed ID: 12007843
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis.
Eberly AR; Wallace MA; Shannon S; Heitman AK; Schuetz AN; Burnham CD; Jean S
J Clin Microbiol; 2022 Apr; 60(4):e0218821. PubMed ID: 35313739
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of cfiA positive Bacteroides fragilis isolates collected at a teaching hospital in Hohhot, China.
Wang Y; Guo B; Gao X; Wen J; Wang Z; Wang J
Anaerobe; 2023 Feb; 79():102691. PubMed ID: 36592651
[TBL] [Abstract][Full Text] [Related]
17. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Liu CY; Huang YT; Liao CH; Yen LC; Lin HY; Hsueh PR
Antimicrob Agents Chemother; 2008 Sep; 52(9):3161-8. PubMed ID: 18625771
[TBL] [Abstract][Full Text] [Related]
18. The first characterized carbapenem-resistant Bacteroides fragilis strain from Croatia and the case study for it.
Bogdan M; Perić L; Ördög K; Vuković D; Urbán E; Sóki J
Acta Microbiol Immunol Hung; 2018 Aug; 65(3):317-323. PubMed ID: 29651861
[TBL] [Abstract][Full Text] [Related]
19. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
Eitel Z; Sóki J; Urbán E; Nagy E;
Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
